Prevention of ER-negative breast cancer

被引：0
|
作者：
Brown, P. H. [1 ,2 ]
机构：
[1] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 03期
关键词：
D O I：
10.1016/S1359-6349(08)70214-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
S22
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [31] EphA2 overexpression in ER-negative metastatic breast cancer cells
    Erzinger, Stephanie A.
    Liu, Hui
    Kiriakova, Galina
    Price, Janet E.
    CLINICAL & EXPERIMENTAL METASTASIS, 2011, 28 (02) : 219 - 219
  • [32] Bioinformatics Analysis in the Identification of Prognostic Signatures for ER-Negative Breast Cancer Data
    Divya, P.
    Suresh, S.
    JOURNAL OF THE INDIAN SOCIETY FOR PROBABILITY AND STATISTICS, 2024, 25 (01) : 1 - 16
  • [33] Contributions of estrogen to ER-negative breast tumor growth
    Gupta, Piyush B.
    Kuperwasser, Charlotte
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2006, 102 (1-5): : 71 - 78
  • [34] Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancer COMMENT
    Peterlongo, Paolo
    Figlioli, Gisella
    Deans, Andrew J.
    Couch, Fergus J.
    NPJ BREAST CANCER, 2021, 7 (01)
  • [35] Cell signaling events differentiate ER-negative subtypes from ER-positive breast cancer
    Maria J. Worsham
    Dhanajay Chitale
    Kang Mei Chen
    Indrani Datta
    George Divine
    Medical Oncology, 2015, 32
  • [36] Cell signaling events differentiate ER-negative subtypes from ER-positive breast cancer
    Worsham, Maria J.
    Chitale, Dhanajay
    Chen, Kang Mei
    Datta, Indrani
    Divine, George
    MEDICAL ONCOLOGY, 2015, 32 (05)
  • [37] Population-based survival-cure analysis of ER-negative breast cancer
    Lan Huang
    Karen A. Johnson
    Angela B. Mariotto
    James J. Dignam
    Eric J. Feuer
    Breast Cancer Research and Treatment, 2010, 123 : 257 - 264
  • [38] Multiple mechanisms of estrogen receptor gene repression contribute to ER-negative breast cancer
    Parl, FF
    PHARMACOGENOMICS JOURNAL, 2003, 3 (05): : 251 - 253
  • [39] Novel role of DAPK-1 in growth regulation of ER-negative breast cancer
    Zhao, Jing
    Zhang, Yun
    Hill, Jamal
    Speers, Corey
    Mazumdar, Abhijit
    Mills, Gordon
    Browns, Powel
    CANCER RESEARCH, 2012, 72
  • [40] RANK is a poor prognosis marker and a therapeutic target in ER-negative postmenopausal breast cancer
    Ciscar, Marina
    Trinidad, Eva M.
    Perez-Chacon, Gema
    Alsaleem, Mansour
    Jimenez, Maria
    Jimenez-Santos, Maria J.
    Perez-Montoyo, Hector
    Sanz-Moreno, Adrian
    Vethencourt, Andrea
    Toss, Michael
    Petit, Anna
    Soler-Monso, Maria T.
    Lopez, Victor
    Gomez-Miragaya, Jorge
    Gomez-Aleza, Clara
    Dobrolecki, Lacey E.
    Lewis, Michael T.
    Bruna, Alejandra
    Mouron, Silvana
    Quintela-Fandino, Miguel
    Al-Shahrour, Fatima
    Martinez-Aranda, Antonio
    Sierra, Angels
    Green, Andrew R.
    Rakha, Emad
    Gonzalez-Suarez, Eva
    EMBO MOLECULAR MEDICINE, 2023, 15 (04)
12345